Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window last week. Beneficial owners were stepping up to the buy window.
August 24, 1:00 PM
Alpha Healthcare Acquisition Corp. (NASDAQ:AHAC) ("AHAC"), a special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination with
July 20, 7:59 AM
Benchmark analyst Bruce Jackson initiates coverage on Alpha Healthcare (NASDAQ:AHAC) with a Buy rating and announces Price Target of $18.
Alpha Healthcare Acquisition Corp. SPAC Merger Partner, Humacyte, Reports Expansion Of Strategic Global Partnership With Fresenius Medical Care
June 11, 7:33 AM
Partnership expanded to include vascular trauma repair outside of the United States. Fresenius Medical Care will adopt the HAV as a standard of care in patients who will benefit from clinical and economic
Humacyte CEO Dr. Laura Niklason Says Vascular Trauma Trial Is Still Underway, Anticipates filing BLA Application Sometime In 2022; If This Were Case, Would Expect First Approval Sometime In 2023
May 25, 11:42 AM